You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Advances in Pulmonary Arterial Hypertension: New Guideline Key Takeaways

  • Authors: Rajan Saggar, MD; Sandhya Murthy, MD
  • CME / CE Released: 9/25/2023
  • Valid for credit through: 9/25/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for cardiologists, pulmonologists, primary care physicians (PCPs), nurses, nurse practitioners (NPs), pharmacists, physician assistants (PAs), and other healthcare providers (HCPs) involved in the care of patients with pulmonary hypertension (PH).

The goal of this activity is for learners to be better able to understand the latest PAH guidelines.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Key changes to the 2022 PAH guidelines
    • Implications of 2022 PAH guidelines for the interprofessional team


Disclosures

Medscape, LLC and Albert Einstein College of Medicine-Montefiore Medical Center requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Rajan Saggar, MD

    Professor of Medicine Director Pulmonary Hypertension Program
    Co-Director Pulmonary Vascular Disease Program Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs
    David Geffen School of Medicine, UCLA
    Los Angeles, California

    Disclosures

    Rajan Saggar, MD, has the following relevant financial relationships:
    Consultant or advisor for: Aerovate; Insmed Incorporated; Janssen Biotech, Inc.; Merck; Third Pole; United Therapeutics
    Speaker or member of speakers bureau for: United Therapeutics
    Research funding from: Aerovate; Janssen Biotech, Inc.; Merck; Third Pole; United Therapeutics
    Contracted researcher for: Aerovate; Janssen Biotech, Inc.; Merck; Third Pole; United Therapeutics

  • Sandhya Murthy, MD

    Associate Professor of Medicine
    Albert Einstein College of Medicine/Montefiore Medical Center
    Bronx, New York

    Disclosures

    Sandhya Murthy, MD, has no relevant financial relationships.

Editors

  • George Boutsalis, PhD

    Senior Director, Content Development, Medscape, LLC

    Disclosures

    George Boutsalis, PhD, has no relevant financial relationships.

  • Frederick Stange, DO

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Frederick Stange, DO, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Pharmacist Planner

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Presented through a collaboration among Albert Einstein College of Medicine-Montefiore Medical Center, and Medscape Education.


Accreditation Statements

montefiore-eins

In support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Albert Einstein College of Medicine-Montefiore Medical Center designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Albert Einstein College of Medicine-Montefiore Medical Center designates this activity for 0.25 nursing contact hours. Nurses should claim only credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Pharmacists

  • Albert Einstein College of Medicine-Montefiore Medical Center designates this continuing education activity for 0.25 contact hour (0.025 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - UAN JA4008224-0000-23-XXX-H01-P and UAN JA4008224-0000-23-XXX-H01-T

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; participants should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit(s)™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Advances in Pulmonary Arterial Hypertension: New Guideline Key Takeaways

Authors: Rajan Saggar, MD; Sandhya Murthy, MDFaculty and Disclosures

CME / CE Released: 9/25/2023

Valid for credit through: 9/25/2024, 11:59 PM EST

processing....

Educational Impact Challenge

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

  • Print